{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:02:02Z","timestamp":1793840522663,"version":"4.6.1"},"reference-count":45,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immune thrombocytopenia (ITP) often presents for the first time in pregnancy, or, in patients with a history of ITP, pregnancy can trigger a relapse. ITP in pregnancy is often mild, leading to minimal or no symptoms; however, treatment may be needed if thrombocytopenia becomes severe, if bleeding occurs, or in anticipation of delivery and neuraxial analgesia. To facilitate the diagnosis of ITP in pregnancy, we present a systematic approach that allows clinicians to first consider urgent pregnancy-related thrombocytopenic conditions such as hypertensive disorders of pregnancy or thrombotic thrombocytopenic purpura; exclude other causes of thrombocytopenia; and determine the need for treatment. We review options for first-line therapies for ITP in pregnancy, including corticosteroids (prednisone or methylprednisolone) and intravenous immune globulin, which has a favorable safety profile in pregnancy, and second-line therapy options that have been used in pregnancy including thrombopoietin receptor agonists, rituximab, and certain immunosuppressant medications such as azathioprine. We summarize the recommendations for platelet targets for delivery, recognizing that the evidence is limited, including a platelet count of 50\u200a\u2009\u00d7\u2009\u200a109\/L or higher for caesarean delivery and 70\u200a\u2009\u00d7\u2009\u200a109\/L or higher for neuraxial anesthesia. Treatment decisions for ITP in pregnancy should be informed by patients' values and preferences along with a multidisciplinary team that includes hematologists, obstetricians, and anesthesiologists.<\/jats:p>","DOI":"10.1182\/hematology.2025000743","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:09:31Z","timestamp":1764943771000},"page":"503-510","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["A practical approach to immune thrombocytopenia in pregnancy"],"prefix":"10.1182","volume":"2025","author":[{"given":"Kristine","family":"Matusiak","sequence":"first","affiliation":[{"name":"1 Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Kinga","family":"Malinowski","sequence":"additional","affiliation":[{"name":"2 Department of Obstetrics and Gynecology and Department of Health Research Methods, Evidence, and Impact"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Arnold","sequence":"additional","affiliation":[{"name":"1 Department of Medicine"},{"name":"3 Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"2","key":"2025120616343234600_hem2025000743C1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.annepidem.2005.06.052","article-title":"Platelet counts differ by sex, ethnicity, and age in the United States","volume":"16","author":"Segal","year":"2006","journal-title":"Ann Epidemiol"},{"issue":"1","key":"2025120616343234600_hem2025000743C2","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1002\/ajh.25321","article-title":"Platelet sequestration and consumption in the placental intervillous space contribute to lower platelet counts during pregnancy","volume":"94","author":"Reese","year":"2019","journal-title":"Am J Hematol"},{"issue":"1","key":"2025120616343234600_hem2025000743C3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1802897","article-title":"Platelet counts during pregnancy","volume":"379","author":"Reese","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"2025120616343234600_hem2025000743C4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00003081-199906000-00017","article-title":"Gestational thrombocytopenia","volume":"42","author":"Shehata","year":"1999","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"2025120616343234600_hem2025000743C5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/bjh.17611","article-title":"Gestational thrombocytopenia: a case-control study of over 3,500 pregnancies","volume":"194","author":"Fogerty","year":"2021","journal-title":"Br J Haematol"},{"issue":"2","key":"2025120616343234600_hem2025000743C6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"issue":"pt B","key":"2025120616343234600_hem2025000743C7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2015.10.024","article-title":"Revisiting HELLP syndrome","volume":"451","author":"Dusse","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"23","key":"2025120616343234600_hem2025000743C8","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"issue":"22","key":"2025120616343234600_hem2025000743C9","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"issue":"8","key":"2025120616343234600_hem2025000743C10","doi-asserted-by":"crossref","first-page":"E327","DOI":"10.1002\/ajh.24404","article-title":"Difficulties in establishing the diagnosis of immune thrombocytopenia: an agreement study","volume":"91","author":"Salib","year":"2016","journal-title":"Am J Hematol"},{"issue":"10","key":"2025120616343234600_hem2025000743C11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2016-04-710285","article-title":"Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy","volume":"128","author":"Sun","year":"2016","journal-title":"Blood"},{"issue":"20","key":"2025120616343234600_hem2025000743C12","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1182\/bloodadvances.2020004162","article-title":"Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv"},{"key":"2025120616343234600_hem2025000743C13","doi-asserted-by":"crossref","first-page":"103619","DOI":"10.1016\/j.jri.2022.103619","article-title":"Adverse effects of prenatal dexamethasone exposure on fetal development","volume":"151","author":"Wang","year":"2022","journal-title":"J Reprod Immunol"},{"key":"2025120616343234600_hem2025000743C14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.reprotox.2017.02.006","article-title":"The relationship between maternal corticosteroid use and orofacial clefts-a meta-analysis","volume":"69","author":"Xiao","year":"2017","journal-title":"Reprod Toxicol"},{"key":"2025120616343234600_hem2025000743C15","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol"},{"key":"2025120616343234600_hem2025000743C16","doi-asserted-by":"crossref","first-page":"985646","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"2025120616343234600_hem2025000743C17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/ejh.12839","article-title":"Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response","volume":"98","author":"Marangon","year":"2017","journal-title":"Eur J Haematol"},{"issue":"5","key":"2025120616343234600_hem2025000743C18","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2025120616343234600_hem2025000743C19","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","article-title":"British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids","volume":"62","author":"Russell","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"20","key":"2025120616343234600_hem2025000743C20","first-page":"2537","article-title":"Romiplostim drug presence in pregnancy and lactation","volume":"141","author":"Labrecque","year":"2023","journal-title":"Blood"},{"key":"2025120616343234600_hem2025000743C21","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211001139","article-title":"Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review","volume":"12","author":"Agarwal","year":"2021","journal-title":"Ther Adv Hematol"},{"issue":"5","key":"2025120616343234600_hem2025000743C22","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/bjh.19161","article-title":"Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonists","volume":"203","author":"Rottenstreich","year":"2023","journal-title":"Br J Haematol"},{"issue":"9","key":"2025120616343234600_hem2025000743C23","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood-2017-01-761262","article-title":"A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy","volume":"130","author":"Kong","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2025120616343234600_hem2025000743C24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajh.26743","article-title":"Romiplostim use in pregnant women with immune thrombocytopenia","volume":"98","author":"Bussel","year":"2023","journal-title":"Am J Hematol"},{"issue":"8","key":"2025120616343234600_hem2025000743C25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1701-2163(16)30729-0","article-title":"Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy","volume":"27","author":"Griffiths","year":"2005","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"2025120616343234600_hem2025000743C26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijoa.2006.10.014","article-title":"Laparoscopic splenectomy in a pregnant patient with immune thrombocytopenic purpura","volume":"16","author":"Felbinger","year":"2007","journal-title":"Int J Obstet Anesth"},{"issue":"3","key":"2025120616343234600_hem2025000743C27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/jcpt.13340","article-title":"Pregnancy outcomes in female patients exposed to cyclosporin-based versus tacrolimus-based immunosuppressive regimens after liver\/kidney transplantation: a systematic review and meta-analysis","volume":"46","author":"Gong","year":"2021","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"2025120616343234600_hem2025000743C28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann Intern Med"},{"issue":"3","key":"2025120616343234600_hem2025000743C29","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/AOG.0000000000003100","article-title":"207: thrombocytopenia in pregnancy","volume":"133","author":"ACOG practice bulletin no","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2025120616343234600_hem2025000743C30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/09537104.2019.1640870","article-title":"Managing ITP and thrombocytopenia in pregnancy","volume":"31","author":"Eslick","year":"2020","journal-title":"Platelets"},{"issue":"suppl 2, pt 2","key":"2025120616343234600_hem2025000743C31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/AOG.0b013e3181c51aeb","article-title":"Perinatal hemorrhagic shock after fetal scalp blood sampling","volume":"115","author":"Sabir","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2025120616343234600_hem2025000743C32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline no. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"issue":"11","key":"2025120616343234600_hem2025000743C33","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1111\/jth.15481","article-title":"Platelet count and indices as postpartum hemorrhage risk factors: a retrospective cohort study","volume":"19","author":"van Dijk","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2025120616343234600_hem2025000743C34","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s12630-019-01420-w","article-title":"Obstetric neuraxial anesthesia at low platelet counts in the context of immune thrombocytopenia: a systematic review and meta-analysis","volume":"66","author":"Bailey","year":"2019","journal-title":"Can J Anaesth"},{"issue":"6","key":"2025120616343234600_hem2025000743C35","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1213\/ANE.0000000000005355","article-title":"The Society for Obstetric Anesthesia and Perinatology interdisciplinary consensus statement on neuraxial procedures in obstetric patients with thrombocytopenia","volume":"132","author":"Bauer","year":"2021","journal-title":"Anesth Analg"},{"issue":"1","key":"2025120616343234600_hem2025000743C36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.htct.2017.11.001","article-title":"Guideline on immune thrombocytopenia in adults: Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associa\u00e7\u00e3o M\u00e9dica Brasileira\u20142018","volume":"40","author":"Ozelo","year":"2018","journal-title":"Hematol Transfus Cell Ther"},{"key":"2025120616343234600_hem2025000743C37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2025.01.019","article-title":"Delphi consensus recommendations for neuraxial anesthesia in adults with platelet disorders and coagulation defects: communication from the ISTH SSC Subcommittee on von Willebrand Factor [published online 12 February 2025]","author":"Peterson","year":"2025","journal-title":"J Thromb Haemost"},{"key":"2025120616343234600_hem2025000743C38","unstructured":"International Society on Thrombosis and Hemostasis. Immune thrombocytopenia and obstetric neuraxial anesthesia at low platelet counts: an international registry. Accessed 11 May 2025. https:\/\/redcap.isth.org\/surveys\/?s=7PPAY4CDCA."},{"issue":"5","key":"2025120616343234600_hem2025000743C39","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/1471-0528.14697","article-title":"Severe primary autoimmune thrombocytopenia in pregnancy: a national cohort study","volume":"125","author":"Care","year":"2018","journal-title":"BJOG"},{"issue":"8","key":"2025120616343234600_hem2025000743C40","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00277-006-0120-6","article-title":"Idiopathic thrombocytopenic purpura in pregnancy: analysis of 43 consecutive cases followed at a single Italian institution","volume":"85","author":"Veneri","year":"2006","journal-title":"Ann Hematol"},{"issue":"10084","key":"2025120616343234600_hem2025000743C41","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post- partum haemorrhage (WOMAN): an international, randomised, double- blind, placebo-controlled trial","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"2025120616343234600_hem2025000743C42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.2022017277","article-title":"Immune thrombocytopenia and pregnancy: an exposed\/nonexposed cohort study","volume":"141","author":"Guillet","year":"2023","journal-title":"Blood"},{"issue":"13","key":"2025120616343234600_hem2025000743C43","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1182\/blood-2002-10-3317","article-title":"A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura","volume":"102","author":"Webert","year":"2003","journal-title":"Blood"},{"issue":"5","key":"2025120616343234600_hem2025000743C44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2014-12-614446","article-title":"Persistent neonatal thrombocytopenia can be caused by IgA antiplatelet antibodies in breast milk of immune thrombocytopenic mothers","volume":"126","author":"Hauschner","year":"2015","journal-title":"Blood"},{"issue":"20","key":"2025120616343234600_hem2025000743C45","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM199311113292005","article-title":"Fetal thrombocytopenia and its relation to maternal thrombocytopenia","volume":"329","author":"Burrows","year":"1993","journal-title":"N Engl J Med"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2025\/1\/503\/2470361\/503matusiak.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2025\/1\/503\/2470361\/503matusiak.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T21:34:44Z","timestamp":1765056884000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2025\/1\/503\/556840\/A-practical-approach-to-immune-thrombocytopenia-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,5]]},"published-print":{"date-parts":[[2025,12,5]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2025000743","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,5]]},"published":{"date-parts":[[2025,12,5]]}}}